According to a recent LinkedIn post from Medsender, the company is drawing attention to referral workflow bottlenecks in dermatology practices following its previously announced partnership with Ezderm. The post suggests that many referrals are still received as standard faxes, getting lost in general queues and leading to delays or missed follow‑ups, described as “referral leakage.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post highlights automation of referral intake as a potential solution, emphasizing same‑day identification, routing, and action on incoming referrals. For investors, this focus implies that Medsender is positioning its platform as an efficiency tool that can reduce leakage and turnaround times, which could enhance its value proposition to specialty practices and support deeper penetration into the dermatology and broader outpatient markets.

